1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Immune Complex Diseases: new trials by email Literature Review of Immune Complex Diseases trials Research Report on Immune Complex Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis Rituximab, Infliximab, Tocilizumab - Giant Cell Arteritis, Takayasu Arteritis | Phase 2 | Terminated | Cambridge University Hospitals NHS Foundation Trust | 22 | 2021-07-14 | 2025-06-17 |
Cogan Syndrome (1) · Cryoglobulinemia, Familial Mixed (1) · Giant Cell Arteritis (1) · IgA Vasculitis (1) · Polyarteritis Nodosa (1) · Polychondritis, Relapsing (1) · Takayasu Arteritis (1) · Vasculitis (1)
Aortic Arch Syndromes (1) · Aortic Diseases (1) · Arteritis (1) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Blood Coagulation Disorders (1) · Brain Diseases (1) · Cardiovascular Diseases (1) · Cartilage Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Connective Tissue Diseases (1) · Cranial Nerve Diseases (1) · Eye Diseases (1) · Hematologic Diseases (1)
Infliximab (1) · Rituximab (1) · tocilizumab (1)
Cambridge University Hospitals NHS Foundation Trust (1)
United Kingdom (1)
David Jayne (1)